Ph.D. WEI-WU HE - 16 Jun 2025 SCHEDULE 13D/A Report for CASI Pharmaceuticals, Inc. Ordinary Shares (CASI)

Filing Manager
Ph.D. WEI-WU HE
Reporting Manager
WEI-WU HE, Ph.D.
Symbol
CASI
Shares outstanding
15,695,525 shares
Disclosed Ownership
3,735,535 shares
Ownership
24%
Form type
SCHEDULE 13D/A
Filing time
20 Jun 2025, 16:30:40 UTC
Date of event
16 Jun 2025
Next filing
18 Dec 2025

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
WEI-WU HE, Ph.D. 24% 3,735,535 2,130,550 1,604,985 /s/ Wei-Wu He, Ph.D. Wei-Wu He, Ph.D. 0001542073
HUIYING MEMORIAL FOUNDATION 2.6% 407,644 0 407,644 /s/ Wei-Wu He, Ph.D. Wei-Wu He, Ph.D./President
EMERGING TECHNOLOGY PARTNERS, LLC 7.1% 1,097,341 0 1,097,341 /s/ Wei-Wu He, Ph.D. Wei-Wu He, Ph.D./ Managing Member
ETP Global Fund L.P. 4.9% 753,234 0 753,234 EMERGING TECHNOLOGY PARTNERS, LLC General Partner
ETP BIOHEALTH III FUND , L.P. 1.9% 300,000 0 300,000 EMERGING TECHNOLOGY PARTNERS, LLC General Partner
HE Family GRAT 0.6% 100,000 0 100,000 /s/ Wei-Wu He, Ph.D. Wei-Wu He, Ph.D./Trustee